Home » Topics » Regulatory » EMA

EMA
RSS

GSK withdraws centralized MAA for Zunrisa in postoperative nausea and vomiting

Oct. 16, 2009

CHMP issues positive opinion for Baxter's Celvapan H1N1 pandemic influenza vaccine

Oct. 6, 2009

E.C. approves Novartis' Focetria vaccine for use in the H1N1 influenza pandemic

Oct. 1, 2009

EMEA withdraws marketing authorization for Posaconazole SP

Aug. 7, 2009

GlaxoSmithKline withdraws MAA for Bosatria

Aug. 3, 2009

European CHMP recommends marketing authorization for Tigenix's ChondroCelect

July 2, 2009

CHMP adopts positive opinion for Otsuka's Samsca in hyponatremia

June 12, 2009

CHMP recommends granting of marketing authorization for Orphan Europe's Vedrop

June 11, 2009

EMEA provides information on possible interaction between clopidogrel and PPIs

June 9, 2009

Sepracor withdraws marketing authorization application for Lunivia (eszopiclone)

May 19, 2009

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...